Lehrstuhl für Strahlentherapie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

GLIO-CMV-01: Identification of immune biomarkers for CMV related encephalitis during standard brain radiotherapy (2017) Rühle PF, Goerig N, Korn K, Überla K, Wunderlich R, Fietkau R, Gaipl U, Frey B Conference contribution Immunological basis of abscopal antitumor responses induced with radio-immunotherapy (2017) Rueckert M, Frey B, Fietkau R, Gaipl U Conference contribution CBCT-based Detection and Analysis of the Positional Stability of implanted Gold Markers and Changes in the Shape of the Rectal Balloon during the Radiotherapy of the Prostate-Ca (2017) Kallis K, Brandt T, Strnad V, Lettmaier S, Fietkau R, Maier AK, Bert C Conference contribution Autologous whole tumor cell-based vaccines generated with high hydrostatic pressure bear immunogenic potential and act synergistically with radiotherapy to retard tumor growth (2017) Frey B, Seitz C, Weiss EM, Rueckert M, Schlücker E, Schaft N, Fietkau R, Gaipl U Conference contribution Brain volume after whole-brain radiotherapy: prognostic relevance and protective factors (2017) Putz F, Hoffmann C, Distel L, Gryc T, Knippen S, Fietkau R Conference contribution A semi-automatic Segmentation Pipeline for sequential Volumetric Analysis of intracranial Tumors (2017) Putz F, Knippen S, Fietkau R Conference contribution Specific Effect of BRAF-Inhibitors on a BRAF-mutant and a Wild-type Cell Line of Malignant Melanoma (2017) Steck M, Grabenbauer M, Fünfle R, Hecht M, Fietkau R, Distel L Conference contribution The prognostic Significance of Tumor-associated Macrophages (TAM) and of Tumor-infiltrating Lymphocytes (TIL) in radiolabelled Patients with an Adenocarcinoma of the Pancreas (2017) Zoske H, Distel L, Fietkau R, Hecht M Conference contribution Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial (2017) Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, et al. Conference contribution Volume Course of Acoustic Neuromas after stereotactic Radiotherapy (2017) Putz F, Lettmaier S, Knippen S, Gryc T, Fietkau R Conference contribution